Table 3 The OARs low dose multi-comparison analysis for all studied techniques (mean ± SD). Mean values with ^ǂ symbol demonstrate that the corresponding technique did not pass the normality test. Friedman test of significance (p < 0.05) was used in these cases; otherwise, repeated measures ANOVA significance test was used

ILung

V ₅ (%)

32.0 ± 5.4^c

37.9 ± 5.2^bc

35.1 ± 4.6^b

52.1 ± 6.3^a

V ₁₀ (%)

20.8 ± 4.5^b

21.0 ± 4.1^b

21.9 ± 3.9^{ǂ b}

25.0 ± 2.7^{ǂ a}

Heart (Lt.)

V ₅ (%)

6.9 ± 3.4^b

7.7 ± 3.3^b

10.9 ± 5.0^b

22.0 ± 5.6^a

V ₁₀ (%)

3.3 ± 2.6^a

2.6 ± 1.9^a

3.6 ± 2.2^{ǂ a}

3.3 ± 1.6^a

Heart (Rt.)

V ₅ (%)

0.5 ± 0.3^a

0.5 ± 0.9^{ǂ a}

1.5 ± 1.5^a

0.7 ± 0.7^a

V ₁₀ (%)

0^{* a}

0^{* a}

0^{* a}

0^{* a}

CBreast

V ₅ (%)

0.5 ± 0.7^ab

0.0 ± 0.1^{ǂ b}

0.4 ± 0.5^{ǂ a}

0.6 ± 0.8 ^a

V ₁₀ (%)

0^{* a}

0^{* a}

0^{* a}

0^{* a}

CLung

V ₅ (%)

0.2 ± 0.5^{ǂ ab}

0.0 ± 0.0^{ǂ b}

0.1 ± 0.3^{ǂ ab}

0.4 ± 0.5^{ǂ a}

V ₁₀ (%)

0^{* a}

0^{* a}

0^{* a}

0^{* a}